The Law Offices of Vincent Wong are investigating the Board of Directors of American Medical Systems Holdings, Inc. (Nasdaq: AMMD) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Endo Pharmaceuticals Holdings, Inc. (Nasdaq: ENDP). Under the terms of the proposed deal, Endo will pay $30 in cash per share for a total transaction value of approximately $2.9 billion, including assumed debt.

The investigation concerns whether the American Medical Board of Directors breached their fiduciary duties to American Medical stockholders by failing to adequately shop the Company before entering into this transaction and whether Endo Pharmaceuticals is underpaying for American Medical shares, thus unlawfully harming American Medical stockholders.

If you own common stock in American Medical and wish to obtain additional information, please contact Vincent Wong, Esq. either via email, by telephone at 212.584.2740, or visit

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010